VanEck Pharmaceutical ETF
91 hedge funds and large institutions have $346M invested in VanEck Pharmaceutical ETF in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 35 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
45.2% more ownership
Funds ownership: 19.22% → 64.42% (+45%)
21% more funds holding
Funds holding: 75 → 91 (+16)
Holders
91
Holding in Top 10
2
Calls
$4.83M
Puts
$1.16M
Top Buyers
| 1 | +$162M | |
| 2 | +$37M | |
| 3 | +$16.3M | |
| 4 |
Morgan Stanley
New York
|
+$11.4M |
| 5 |
NC
Noked Capital
Tel Aviv,
Israel
|
+$10.8M |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$1.4M | |
| 3 | -$967K | |
| 4 |
GA
GFS Advisors
Houston,
Texas
|
-$518K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$504K |